Skip to main content
Notice2021-28386

Statement of Organization, Functions, and Delegations of Authority

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
January 3, 2022

Issuing agencies

Health and Human Services DepartmentFood and Drug Administration

Abstract

The Food and Drug Administration's (FDA), Center for Biologics Evaluation and Research (CBER), Center for Drug Evaluation and Research (CDER), Center for Devices and Radiological Health (CDRH), and Center for Tobacco Products (CTP) have modified their organizational structures. These new organizational structures were approved by the Deputy Secretary of Health and Human Services and effective on November 24, 2021.

Indexed from Federal Register on January 3, 2022.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.